Tag
Quarterly review
3 articles tagged with "Quarterly review"
October 2, 20264 min read
Twine Saver, Q3 2026: the quarter in company building
Fewer but larger life science deals, contingent pay in nearly every one of them, a selective IPO window, a Federal Reserve that turned to tightening, and business formation that peaked in July. A look back at July through September 2026.
Intertwine Partners
Twine SaverQuarterly reviewMarkets
Read Article
October 2, 20264 min read
Twine Saver, Q3 2026: business formation and corporate strategy
New business applications peaked in July and cooled in August. Companies reshaped themselves through carve-outs, roll-ups, reverse mergers and acquisitions of AI and data businesses, while the cost of capital rose.
Intertwine Partners
Twine SaverQuarterly reviewStrategy
Read ArticleOctober 2, 20265 min read
Twine Saver, Q3 2026: life science deals and public markets
The quarter's acquisitions, licences and IPOs in biotech, pharma, medtech and contract manufacturing, and the deal structures that ran through them: contingent value rights, asset-only purchases and strategic investors in IPOs.
Intertwine Partners
Twine SaverQuarterly reviewLife sciencesMarkets
Read Article